Patent details

Basic Information

Publication number:

EP2590969

PCT Application Number:

PCT/GB/2011/051256

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117294587

PCT Publication Number:

WO/2012/004588

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Therapeutic agents 976

French Title of Invention:

Agents thérapeutiques 976

German Title of Invention:

Therapeutika 976

SPC Number:

Dates

Filing date:

04/07/2011

Grant date:

15/10/2014

EP Publication Date:

15/10/2014

PCT Publication Date:

12/01/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/05/2013

EP B1 Publication Date:

15/10/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/07/2015

Expiration date:

04/07/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/07/2011

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:

VON UNGE Per Oskar, Sverker

Address:

Sweden (SE)

2

Name:

LÖFBERG Björn, Christian, Ingvar

Address:

Sweden (SE)

3

Name:

BÖKMAN-WINIWARTER Susanne, Doris, Margit

Address:

Sweden (SE)

4

Name:

HOGNER Anders, Carl

Address:

Sweden (SE)

5

Name:

LI Lanna

Address:

United Kingdom (GB)

6

Name:

JUDKINS Robert, Andrew

Address:

Sweden (SE)

7

Name:

JOHANSSON Lars Anders, Mikael

Address:

Sweden (SE)

8

Name:

FREDENWALL Marlene

Address:

Sweden (SE)

Priority

Priority Number:

361585 P

Priority Date:

06/07/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 413/06;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages